Almost every first conversation we have with a new brand includes some version of the same question, usually phrased with an apology attached: what is the actual difference between OEM, ODM and private label? It is a fair question and a badly served one. Most explanations online define the acronyms and stop, which is the least useful part. The acronyms are easy. What matters is that the three models allocate formula ownership, development time, cost structure and risk differently, and picking the wrong one is expensive in ways that only become visible six months in.
This article sets out what actually changes between the three, which questions decide it, and the specific situations where the obvious answer is the wrong one.
The Short Version
- Private label — you take a formula that already exists, put your brand on it, and ship. You do not own the formula and it is not exclusive to you.
- ODM (Original Design Manufacturer) — the manufacturer develops a formula against your brief and produces it. You own the positioning and, depending on the agreement, some or all of the formula rights.
- OEM (Original Equipment Manufacturer) — you bring the formula or a locked specification and the manufacturer produces it to that spec. You own the formula; the factory sells you capacity.
The common framing is that these are three points on a scale from cheap-and-fast to expensive-and-slow. That framing is close enough to be useful and wrong in one important way: OEM, which sits at the "most control" end, is not the most expensive route for everyone. It is the cheapest route for a brand that already owns a formula, and an impossible route for one that does not.
What Actually Changes Between Them
Who owns the formula
This is the question that determines everything else, and it is the one most often left vague in a first quote.
Under private label, the base formula belongs to the manufacturer and is offered to multiple brands. You may be able to negotiate a small customisation — fragrance, colour, sometimes an active at a modified level — but the underlying formula is shared. A competitor can launch a near-identical product, and eventually one usually does.
Under ODM, the formula is developed for your brief. Whether you own it afterwards is a contractual question, not a definitional one, and the answers range from full transfer, to exclusivity for a defined period or category, to no exclusivity at all. Ask explicitly, and get the answer in the agreement. A brand that assumes exclusivity it never negotiated has bought a private label product at ODM prices.
Under OEM, you already own the formula. The manufacturer produces to your specification and should have no claim on it. The risk shifts: because the formula is yours, its performance, stability and compliance are also yours.
What it costs you in time
Time is where the three models separate most sharply, and time is usually what a first-time brand underestimates.
Private label is the fastest because the slow part has already happened — the formula exists, the stability data exists, and often the packaging is already qualified against it. What remains is artwork, regulatory work for your market, and production.
ODM adds a development cycle: brief, first prototypes, revision rounds, then stability and challenge testing. Revision rounds are the variable that brands control and most often mishandle. Each round costs calendar time, and the number of rounds correlates with how vague the brief was, not with how demanding the brand is. A precise brief with a defined sensory target and claim direction is the single cheapest thing you can bring to an ODM project.
OEM sits in between, and its timeline depends on how transferable your formula is. A well-documented formula with named raw materials and an established process transfers quickly. A formula documented only as "what the previous factory made" needs to be reconstructed, which is ODM work billed as OEM.
In all three, stability and challenge testing occupy a fixed block of calendar time that cannot be compressed by paying more. This surprises people. It is the reason a launch date set from a marketing calendar rather than a production calendar tends to slip.
Who carries which risk
- Under private label, the manufacturer carries formulation and stability risk. You carry differentiation risk — the product is good, and so is your competitor's, because it is the same product.
- Under ODM, risk is shared. The manufacturer is responsible for the formula performing as specified; you are responsible for the brief describing a product the market wants.
- Under OEM, you carry most of it. If the formula fails stability at scale, that is your formula.
What it costs
Development cost rises from private label to ODM. Per-unit cost is a different question and does not follow the same order — it is driven by formula cost, packaging and volume, not by which model you chose. A private label product in an expensive component can easily cost more per unit than an ODM product in a stock bottle.
The comparison that actually matters is total cost to reach a shelf, which includes development, testing, packaging tooling, registration in each destination market, and the first production run. Comparing only the per-unit quote across two manufacturers on two different models produces a meaningless number.
Which One Should You Choose
Four questions settle it in most cases.
1. Do you already own a formula? If yes, you are looking at OEM, and the remaining question is whether your documentation is complete enough to transfer. If no, OEM is not available to you no matter how much control you want.
2. Is your differentiation the formula, or everything around it? Be honest here, because it is the question brands most often answer aspirationally. If your positioning is a specific texture, a specific active complex, or a claim you intend to substantiate, you need ODM development against your brief. If your differentiation is brand, packaging, channel and the market you sell into — which is a completely legitimate and frequently more profitable position — private label manufacturing gets you there sooner and with less capital at risk.
3. What is your realistic first-order volume? Development cost is amortised across units. An ODM programme spread over a small first run carries a high effective cost per unit; the same programme over a larger run does not. This is not a reason to over-order — it is a reason to be realistic about which model your volume supports. How volume, format, packaging and market interact is covered in what actually determines cosmetic MOQ.
4. How fixed is your launch date? A date driven by a trade show, a retailer window or a funding milestone constrains the model. If the date cannot move and it is tight, private label is often the only honest answer, and starting with private label to hit a window while developing an ODM hero product for the following season is a sound sequence rather than a compromise.
Where the Obvious Answer Is Wrong
"We want full control, so OEM." Control you cannot exercise is not control. A brand without formulation capability that insists on OEM ends up paying a consultant to develop a formula, then paying a factory to produce it, with no single party accountable when something fails at scale. ODM puts formulation and production under one responsibility. Choose OEM because you have a formula, not because you want authority.
"Private label means low quality." It does not. It means non-exclusive. The formula in a good private label catalogue was developed by the same lab, to the same standard, that does the ODM work — it was simply developed speculatively rather than to one brand's brief. The trade-off is exclusivity, not quality.
"ODM means we own the formula." Only if the agreement says so. This is the single most common and most costly misunderstanding in this category. Formula ownership, exclusivity scope and exclusivity duration are three separate terms and each must be written down.
"We will start with ODM because we will need it eventually." Sometimes right, often not. Launching a private label product first gives you real sell-through data before you commit development spend, and a brief written after six months of actual customer feedback is a far better brief. See how custom cosmetic formulation work is scoped once that data exists.
How This Plays Out in Practice
A concrete example. A brand wants to launch around a trending active — say a PDRN serum built under an ODM or private label programme.
Under private label, they select an existing base, adjust fragrance and packaging, and are in market for the season. The product is good. Two competitors launch something very similar, because they can.
Under ODM, they brief a specific complex, a specific texture and a claim direction, iterate through prototypes, run stability, and launch a season later at a higher development cost with a product their competitors cannot copy from a catalogue.
Neither is wrong. The first is right if the brand's advantage is distribution and audience; the second is right if the advantage is the product itself. What is wrong is choosing between them on price alone, or choosing ODM for prestige and then briefing it so loosely that the result is indistinguishable from the catalogue base they would have paid less for.
Frequently Asked Questions
Is ODM always more expensive than private label?
In development cost, yes. In per-unit cost, not necessarily — unit cost is driven by formula, packaging and volume rather than by the model. And in total cost to reach a shelf, an ODM product that sells through can be cheaper than a private label product that does not differentiate and sits in a warehouse. Compare total cost against realistic sell-through, not quotes side by side.
Can I switch from private label to ODM later?
Yes, and it is a common and sensible sequence. Launch on private label to validate the market, then develop an ODM hero product using what you learned. The one thing to plan for is that the two products may not be identical in texture or performance, so position the ODM version as an upgrade rather than a silent replacement.
Do I own the formula in an ODM project?
Only if your agreement says you do. Formula ownership, exclusivity scope and exclusivity duration are three separate terms, and none of them is implied by the word ODM. Raise all three before development starts — renegotiating after the formula exists is much harder.
What is white label, and how is it different from private label?
In practice the two terms are used interchangeably in cosmetics, and both describe applying your brand to an existing formula. Where people do distinguish them, white label suggests a completely generic product offered to anyone, while private label suggests some degree of customisation. The distinction is not standardised, so define what you mean rather than relying on the term.
Which model do most new K-beauty brands start with?
Most start with private label or a lightly customised ODM programme, for the straightforward reason that development capital is scarce at launch and market validation is worth more than exclusivity in year one. Brands with an existing formula, or with a positioning that no catalogue base can express, are the exceptions — and for them starting with ODM or OEM is the right call rather than an extravagance.